跳至主要内容
临床试验/CTRI/2025/06/088944
CTRI/2025/06/088944尚未招募2/3 期

A Comparative Clinical Study to evaluate the efficacy of Suranawleha and Suranvatak in the management of Shushka Arsha with special reference to Haemorrhoids.

Department of Shalyatantra,Shree Saptashrungi Ayurveda Mahavidyalay1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年6月26日最近更新:
适应症

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
To reduce signs and symptoms of constipation,anal itching in management of Shushka arsha with special reference to Haemorrhoids

研究概览

简要总结

Study Title:

A Comparative Clinical Study to Evaluate the Efficacy of Suranawleha and Suranvatak in the Management of Shushka Arsha with Special Reference to Haemorrhoids

Background:

Shushka Arsha, correlating with dry-type haemorrhoids, is a common anorectal disease which is well known for its chronicity, recurrences &

frequent acute exacerbations .Ayurvedic literature offers various herbal formulations for its management, among which Suranawleha and Suranvatak can be used.

Objective:

1.Primary Objective

To study the effect of Suranawleha as compared to Suranvatak in management of Shushka Arsha wsr to Haemorrhoids .

2.Secondary Objective

  1. To study in detail Arsha as per Ayurvedic literature.

  2. To study in detail Haemorrhoids as per Modern science.

  3. To study in detail about the drug Suranawleha.

Design: Comparative clinical trial

Participants:

Patients diagnosed with Shushka Arsha (1st & 2 nd degree piles) of ahe group 16-80 years meeting the inclusion and exclusion criteria will be selected from OPD and IPD of Shalyatantra department of Shree Saptashrungi Ayurveda Mahavidyalaya and Hospital, Nashik.

Intervention Groups:

Group A: Treated with Suranawleha

Group B: Treated with Suranvatak

Duration:

Treatment duration:21 days

Follow up on 7 ,14 & 21 st day

Assessment Criteria:

Symptomatic relief (pain, constipation), reduction in pile mass, and overall quality of life.

Expected Outcome:

The study aims to determine which formulation provides better symptomatic relief and therapeutic outcomes, thereby guiding effective Ayurvedic management protocols for haemorrhoids.

Overall Assessment of Therapy:

Observations and results will be formulated in accordance with the assessment

criteria.

12.Conclusion:

The conclusion will be derived exclusively from the statistical analysis.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •Patients having symptoms of Arsha (1st and 2nd degree piles) 2) Patients of age groups 18-60 years irrespective of gender,socioeconomic status .
  • •Patients who are willing to participate in the study and ready to give informed written consent.

排除标准

  • •Thrombosed prolapsed piles, third, and 4th degree piles .
  • •Patient suffering from anorectal pathology other than Arsha.
  • •Patient below age group under 18 years and above 70 years.
  • •Patients suffering from any serious systemic diseases like hypertension, diabetes mellitus , malignancy, Hepatitis B, HIV, HCV, Tuberculosis 5) Bleeding per rectum.

结局指标

主要结局

To reduce signs and symptoms of constipation,anal itching in management of Shushka arsha with special reference to Haemorrhoids

时间窗: 21 days

次要结局

  • To provide long term relief & reduce recurrence(21 days)

研究者

发起方
Department of Shalyatantra,Shree Saptashrungi Ayurveda Mahavidyalay
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验